@dansfera: From humble beginnings to a massive $600 million valuation in just seven years—Headlands Research is proving that clinical research is a goldmine. After THL Partners acquired a majority stake, the big question remains: how did they scale this quickly, and what does the endgame look like? A fascinating deep dive into the business of biotech and the KKR connection. #HeadlandsResearch #BiotechBusiness #ValuationAnalysis #ClinicalResearch #InvestmentStrategy